KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesReal Estate - GrossReal Estate - NetReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Accumulated Depreciation (2016 - 2026)

Omega Healthcare Investors' Accumulated Depreciation history spans 17 years, with the latest figure at $2.9 billion for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation rose 5.43% to $2.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.9 billion, a 5.43% increase, with the full-year FY2025 number at $2.9 billion, up 7.7% from a year prior.
  • Accumulated Depreciation hit $2.9 billion in Q1 2026 for Omega Healthcare Investors, roughly flat from $2.9 billion in the prior quarter.
  • Over the last five years, Accumulated Depreciation for OHI hit a ceiling of $2.9 billion in Q4 2025 and a floor of $2.2 billion in Q1 2022.
  • Historically, Accumulated Depreciation has averaged $2.6 billion across 5 years, with a median of $2.5 billion in 2024.
  • Biggest five-year swings in Accumulated Depreciation: increased 3.32% in 2022 and later increased 10.17% in 2024.
  • Tracing OHI's Accumulated Depreciation over 5 years: stood at $2.3 billion in 2022, then grew by 6.33% to $2.5 billion in 2023, then rose by 10.17% to $2.7 billion in 2024, then increased by 7.7% to $2.9 billion in 2025, then decreased by 0.01% to $2.9 billion in 2026.
  • Business Quant data shows Accumulated Depreciation for OHI at $2.9 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.9 billion in Q3 2025.